EUVIMEDEUVIMED entdecken
Open Access

Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic targetTOP2A in ACC

Jianming Lu, Pei Deng, Zhenjie Wu, Yuxiang Liang, Yangjia Zhuo, Yongding Wu, Yingke Liang, Jianheng Ye, Wenjie Xie, Zhouda Cai, Chao Cai, Jiahong Chen und 5 weitere

Acta Biochimica et Biophysica Sinica · 2025

DOI: 10.3724/abbs.2025144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2025. Verfasst von Jianming Lu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Andrology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China. Hauptthemen laut MEDLINE: Poly-ADP-Ribose Binding Proteins, DNA Topoisomerases, Type II, Adrenocortical Carcinoma, Adrenal Cortex Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly-ADP-Ribose Binding ProteinsDNA Topoisomerases, Type IIAdrenocortical CarcinomaAdrenal Cortex NeoplasmsBiomarkers, TumorHumansCell Line, TumorTopoisomerase II InhibitorsAnimalsFemaleGene Expression Regulation, NeoplasticPrognosisMaleMiceMultiomics

Stichwörter der Autor:innen

TOP2Aadrenocortical carcinomaimmunotherapy responseprognosistherapeutic inhibitors

Substanzen

TOP2A protein, humanPoly-ADP-Ribose Binding ProteinsDNA Topoisomerases, Type IIBiomarkers, TumorTopoisomerase II Inhibitors

Autor:innen und Institutionen

  • Department of Andrology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.
  • Department of Urology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
  • Department of Urology, Minimally Invasive Surgery Center, the First Affiliated Hospital of Guangzhou Medical University, Guangdong Key Laboratory of Urology, Guangzhou Institute of Urology, Guangzhou 510230, China.
  • Department of Urology, Huizhou Municipal Central Hospital, Huizhou 516008, China.
  • Institute for Integrative Genome Biology, University of California, Riverside, California 92507, USA.
  • State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau 999078, China.

Zitieren

APA

Lu, J., Deng, P., Wu, Z., Liang, Y., Zhuo, Y., Wu, Y., Liang, Y., Ye, J., Xie, W., Cai, Z., Cai, C., Chen, J., Zhang, L., Deng, J., Zhong, W., Tang, J., & Han, Z. (2025). Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic targetTOP2A in ACC. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025144

Vancouver

Lu J, Deng P, Wu Z, Liang Y, Zhuo Y, Wu Y, et al. Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic targetTOP2A in ACC. Acta Biochimica et Biophysica Sinica. 2025. doi:10.3724/abbs.2025144

BibTeX
@article{Lu2025,
  author = {Lu, Jianming and Deng, Pei and Wu, Zhenjie and Liang, Yuxiang and Zhuo, Yangjia and Wu, Yongding and Liang, Yingke and Ye, Jianheng and Xie, Wenjie and Cai, Zhouda and Cai, Chao and Chen, Jiahong and Zhang, Le and Deng, Junhong and Zhong, Weide and Tang, Jiaojiao and Han, Zhaodong},
  title = {Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic targetTOP2A in ACC},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2025},
  doi = {10.3724/abbs.2025144}
}
Kostenlos starten →